SERMs and SERMs with estrogen for postmenopausal osteoporosis [0.03%]
选择性雌激素受体调节剂和与雌激素联用的选择性雌激素受体调节剂治疗绝经后骨质疏松症
Michael A Bolognese
Michael A Bolognese
Bone loss with aging places postmenopausal women at a higher risk for osteoporosis and its consequences such as fractures, pain, disability, and increased morbidity and mortality. Approximately 200 million patients worldwide are affected. T...
Compliance and persistence with osteoporosis medications: a critical review of the literature [0.03%]
骨质疏松症药物的依从性和持久性：文献批判性回顾
Stuart Silverman,Deborah T Gold
Stuart Silverman
It is widely acknowledged that compliance and persistence with oral osteoporosis medications, particularly with bisphosphonates, is poor. Several excellent reviews have been written on compliance and persistence with osteoporosis medication...
Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus [0.03%]
糖尿病患者冠心病的诊断和预后评估检查
Neal B Patel,Gary J Balady
Neal B Patel
Coronary artery disease (CAD) continues to be the most common cause of morbidity and mortality in patients with diabetes mellitus (DM). In recent years, the strategies for treatment of CAD in DM have undergone much evolution. Currently, all...
Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting [0.03%]
糖尿病合并冠心病的血运重建：支架植入术、旁路移植手术及成形术
Doron Aronson,Elazer R Edelman
Doron Aronson
Patients with diabetes mellitus (DM) are prone to a diffuse and rapidly progressive form of atherosclerosis, which increases their likelihood of requiring revascularization. However, the unique pathophysiology of atherosclerosis in patients...
Fredrick L Dunn
Fredrick L Dunn
Cardiovascular disease is a major complication of type 2 diabetes mellitus, and this is partly due to associated abnormalities of plasma lipid and lipoprotein metabolism. Although glycemic control improves plasma lipoprotein abnormalities a...
David C Aron
David C Aron
Practicing and perfecting the art of medicine demands recognition that uncertainty permeates all clinical decisions. When delivering clinical care, clinicians face a multiplicity of potential diagnoses, limitations in diagnostic capacity, a...
Overview of the importance of glycaemic control for cardiovascular events in the in-and out-patient setting [0.03%]
glycemic控制在心血管事件中的作用概述：住院与门诊患者的差异
Matteo Anselmino,Klas Malmberg,Linda Mellbin et al.
Matteo Anselmino et al.
Worldwide prevalence of diabetes mellitus in the adult population is increasing and when explicitly searched within specific groups of patients, as those presenting cardiovascular disease (CVD), dysglycaemia is detected in about three-quart...
Impact of cardiovascular outcomes on the development and approval of medications for the treatment of diabetes mellitus [0.03%]
心血管结局对糖尿病治疗药物研发和审批的影响
Hylton V Joffe,Mary H Parks,Robert Temple
Hylton V Joffe
All medications currently approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes mellitus are indicated to improve glycemic control. Since 1995, FDA has used HbA1c as the primary basis for approval of these ...
Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community [0.03%]
2型糖尿病与社区人群心脏性猝死风险的关系
David S Siscovick,Nona Sotoodehnia,Thomas D Rea et al.
David S Siscovick et al.
The reduction of mortality from sudden cardiac arrest (SCA) in the setting of coronary heart disease (CHD) remains a major challenge, especially among patients with type 2 diabetes. Diabetes is associated with an increased risk of SCA, at l...
The economic consequences of diabetes and cardiovascular disease in the United States [0.03%]
美国糖尿病和心血管疾病的经济影响
Miguel A Ariza,Varsha G Vimalananda,James L Rosenzweig
Miguel A Ariza
Diabetes-related care and complications constitute a significant proportion of the United States' (US) health care expenditure. Of these complications, cardiovascular disease (CVD) is a major component. Higher morbidity and mortality rates ...